| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $58M |
Buys | $13,258,726 | 7 | 100 |
Sells | $0 | 0 | 0 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7 | $13.26M | 0 | $0 | $13.26M |
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Over the last 12 months, insiders at Benitec Biopharma Inc. have bought $13.26M and sold $0 worth of Benitec Biopharma Inc. stock.
On average, over the past 5 years, insiders at Benitec Biopharma Inc. have bought $6.63M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SUVRETTA CAPITAL MANAGEMENT, LLC () — $13.26M.
The last purchase of 16,497 shares for transaction amount of $211,736 was made by SUVRETTA CAPITAL MANAGEMENT, LLC () on 2025‑03‑31.
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC | 16,497 0.0638% | $12.83 | $211,736 | +4.82% | |||
| 2025-03-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | 900,000 3.561% | $13.00 | $11.7M | -2.75% | |||
| 2024-12-24 | SUVRETTA CAPITAL MANAGEMENT, LLC | 20,018 0.0838% | $11.25 | $225,203 | +7.64% | |||
| 2024-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC | 27,502 0.1165% | $10.98 | $301,972 | +10.50% | |||
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC | 42,000 0.1737% | $9.60 | $403,200 | +22.00% | |||
| 2024-11-20 | SUVRETTA CAPITAL MANAGEMENT, LLC | 27,436 0.113% | $10.22 | $280,396 | +14.17% | |||
| 2024-11-19 | SUVRETTA CAPITAL MANAGEMENT, LLC | 14,000 0.0584% | $9.73 | $136,220 | +22.82% | |||
| 2023-08-11 | BUCHI J KEVIN | director | 51,813 <0.0001% | $0.00 | $5 | +28.83% | ||
| 2023-08-11 | Boston Megan | Executive Director | 25,907 <0.0001% | $0.00 | $3 | +28.83% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8807805 34.4052% | $120.36M | 7 | 0 | ||
| BUCHI J KEVIN | director | 52097 0.2035% | $711,905.51 | 1 | 0 | +28.83% |
| Boston Megan | Executive Director | 25907 0.1012% | $354,019.16 | 1 | 0 | +28.83% |
$21,575,910 | 89 | 3.57% | $342.04M | |
$18,554,304 | 31 | -11.72% | $340.46M | |
$3,668,031 | 23 | 1.97% | $329.96M | |
$24,857,912 | 21 | -35.40% | $382.65M | |
$26,923,982 | 20 | -17.22% | $345.61M | |
$46,442,839 | 15 | -20.05% | $362.98M | |
$109,488,423 | 15 | 56.69% | $367.1M | |
$7,254,955 | 14 | 20.70% | $374.25M | |
$152,858,569 | 14 | -4.66% | $377.08M | |
$1,037,470 | 13 | 78.00% | $329.52M | |
$65,355,913 | 13 | -3.42% | $369.55M | |
$81,667,942 | 12 | -57.54% | $344.41M | |
$19,659,196 | 11 | 21.81% | $337.37M | |
$133,369,382 | 10 | 5.02% | $342.79M | |
$4,706,376 | 8 | 42.30% | $323.94M | |
$356,211 | 4 | 32.45% | $360.39M | |
$602,180 | 4 | -26.17% | $357.31M | |
Benitec Biopharma Inc. (BNTC) | $8 | 2 | 28.83% | $349.83M |
$504,640 | 1 | 16.84% | $380.1M |
| Increased Positions | 25 | +108.7% | 3M | +15.98% |
| Decreased Positions | 9 | -39.13% | 141,593 | -0.75% |
| New Positions | 9 | New | 567,658 | New |
| Sold Out Positions | 3 | Sold Out | 37,587 | Sold Out |
| Total Postitions | 39 | +69.57% | 22M | +15.23% |
| Suvretta Capital Management, Llc | $134,848.00 | 34.46% | 8.96M | +130,956 | +1.48% | 2024-12-31 |
| Franklin Resources Inc | $44,236.00 | 11.31% | 2.94M | +2M | +268.96% | 2024-12-31 |
| Janus Henderson Group Plc | $39,377.00 | 10.06% | 2.62M | +2M | +198.5% | 2024-12-31 |
| Adage Capital Partners Gp, L.L.C. | $29,686.00 | 7.59% | 1.97M | +1M | +134.44% | 2024-12-31 |
| Nantahala Capital Management, Llc | $12,613.00 | 3.22% | 838,095 | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $4,515.00 | 1.15% | 300,021 | +86,954 | +40.81% | 2024-12-31 |
| Schonfeld Strategic Advisors Llc | $3,919.00 | 1% | 260,417 | -12,400 | -4.54% | 2024-12-31 |
| Infinitum Asset Management, Llc | $3,161.00 | 0.81% | 210,000 | +210,000 | New | 2024-12-31 |
| Geode Capital Management, Llc | $2,966.00 | 0.76% | 197,096 | +113,109 | +134.67% | 2024-12-31 |
| Blackrock, Inc. | $2,776.00 | 0.71% | 184,426 | +10,673 | +6.14% | 2025-03-31 |